Desktop Health Validates Flexcera Smile Ultra+ Resin For Dental Implantology
Portfolio Pulse from Benzinga Newsdesk
Desktop Health has validated its Flexcera Smile Ultra+ resin for use in dental implantology, specifically for All-on-X implant-supported denture prosthetics. The global dental implant and prosthetics market is projected to reach $16 billion by 2029.
July 29, 2024 | 12:42 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Desktop Health, a subsidiary of Desktop Metal (DM), has validated its Flexcera Smile Ultra+ resin for dental implantology, which could significantly boost its market presence in the growing dental implant and prosthetics market projected to reach $16 billion by 2029.
The validation of Flexcera Smile Ultra+ resin for dental implantology by Desktop Health is a significant milestone. Given the projected growth of the dental implant and prosthetics market to $16 billion by 2029, this development could enhance Desktop Metal's market position and revenue potential.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100